Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation

This publication has 4 references indexed in Scilit:

• Anti–B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome
  Blood, 1998
• Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders
  The Lancet, 1998
• Complete Sustained Response of a Refractory, Post-Transplantation, Large B-Cell Lymphoma to an Anti-CD22 Immunotoxin
  Annals of Internal Medicine, 1997
• REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
  The Lancet, 1984